Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.
Evolent Health, Inc. (NYSE: EVH) plays a pivotal role in the healthcare sector by supporting health systems and physician organizations in their transition to value-based care and population health management. Headquartered in Arlington, Virginia, Evolent is backed by major entities such as The Advisory Board Company, University of Pittsburgh Medical Center Health Plan, and TPG Growth. The company’s core business revolves around providing integrated specialty care management services, total cost of care management, and health plan administration through an all-inclusive platform.
Evolent specializes in managing complex conditions in fields such as oncology, cardiology, and musculoskeletal markets, aiming to simplify healthcare and make it more affordable. The company's recent achievements include exceeding profitability expectations in the third quarter of 2023, adding new operating partnerships, and enhancing its financial outlook for the year. Evolent reported robust financial health with $184.5 million in cash and cash equivalents as of September 30, 2023.
The company’s culture is centered around collaboration, innovation, and a supportive work environment. Benefits like treadmill desks, healthy snacks, and wellness challenges underscore its commitment to employee well-being.
Notably, Evolent is also venturing into AI-driven healthcare solutions, as evidenced by its recent agreement to acquire Machinify Auth, a software platform that enhances clinical quality through advanced AI. This acquisition is expected to significantly improve the speed and efficiency of clinical reviews for various conditions.
In summary, Evolent Health continues to be a significant player in the healthcare industry, driving better health outcomes and financial performance through innovative solutions.
FAQ
What is the current stock price of Evolent Health (EVH)?
The current stock price of Evolent Health (EVH) is $10.17 as of January 21, 2025.
What is the market cap of Evolent Health (EVH)?
The market cap of Evolent Health (EVH) is approximately 1.2B.
What is the primary business of Evolent Health, Inc.?
Evolent Health, Inc. supports health systems and physician organizations in transitioning to value-based care and population health management.
Where is Evolent Health headquartered?
Evolent Health is headquartered in Arlington, Virginia.
What recent financial achievements has Evolent Health reported?
Evolent Health exceeded profitability expectations in Q3 2023 and reported $184.5 million in cash and cash equivalents as of September 30, 2023.
What are some of the core services provided by Evolent Health?
Evolent Health provides specialty care management, total cost of care management, and health plan administration services.
What recent acquisition did Evolent Health announce?
Evolent Health announced the acquisition of Machinify Auth, an AI-powered software platform for clinical reviews.
Who are some of the backers of Evolent Health?
Evolent Health is backed by The Advisory Board Company, University of Pittsburgh Medical Center Health Plan, and TPG Growth.
What are the primary specialty care areas Evolent focuses on?
Evolent focuses on oncology, cardiology, and musculoskeletal care.
How does Evolent Health view its company culture?
Evolent Health promotes a collaborative and innovative work environment with benefits like treadmill desks and wellness challenges.
What is the significance of Evolent’s acquisition of Machinify Auth?
The acquisition is expected to enhance Evolent’s capabilities in AI-driven healthcare, improving the efficiency of clinical reviews.
How has Evolent Health performed financially in recent quarters?
Evolent Health has reported strong financial performance, with increased profitability, new partnerships, and a solid financial outlook for the year.